Corrigendum: LncRNA DCST1-AS1 Promotes Endometrial Cancer Progression by Modulating the MiR- 665/HOXB5 and MiR-873-5p/CADM1 Pathways
Jie Wang, Pingping Shi, Huaixiang Teng and 3 more
Frontiers in Oncology · 2022
doi:10.3389/fonc.2022.819908 (opens in a new tab)
We email you when a new notice or a question about this paper appears.
Abstract
Corrigendum: LncRNA DCST1-AS1 promotes endometrial cancer progression by modulating the miR- 665/HOXB5 and miR-873-5p/CADM1 pathwaysJie Wang1†, Pingping Shi2*†, Huaixiang Teng3, Lixiang Lu4, Hailong Guo2 and Xiuqin Wang21Gynaecology Clinic, People’s Hospital of Rizhao, Rizhao, China2No. 2 Department of Gynaecology, People’s Hospital of Rizhao, Rizhao, China3Reproductive Medicine Center, Maternal and Child Health Hospital of Rizhao, Rizhao, China4No. 2 Department of Gynaecology, Baiqiuen Hospital of Rizhao, Rizhao, China†These authors have contributed equally to this work* Correspondence: Pingping Shiqwek152@163.comKeywords: Keywords: endometrial cancer, long noncoding RNA, DC-STAMP domain-containing 1-antisense 1, microRNA-665, homeobox B5, microRNA-873-5p, cell adhesion molecule 1Corrigendum on: full citation of the original version of the article. Removal of one authorIn the original article, Changjiang Lei was designated as one of the authors. Changjiang Lei has now been removed from the author list. The authors apologize for this negligence and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Abstract licence: CC BY
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.